Refine by
Process Analysis Articles & Analysis
53 news found
Over the past decade, the use of the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanoderived therapeutics and their translation into commercially viable products has been proven to be highly effective in terms of maintaining the overall stability of pharmaceutical formulations. ...
Customers will be able to experience these benefits across a range of critical business functions, including transaction processing, health outcomes analytics, and compliance adherence. "Completion of this important strategic acquisition enables us to deliver best-in-class data and system interoperability services to the healthcare and life sciences sectors powered by ...
BOC Sciences, a tech-driven company, is delighted to announce that its team will be participating in the prestigious Drug Discovery Chemistry (DDC) conference in April 2024. The company will be situated at booth #117, showcasing its quality chemical materials and advanced technologies. DDC is an annual event that gathers researchers, scientists, and experts from across the globe who are involved ...
The upgraded TCR-Seq technology leverages advanced sequencing techniques and cutting-edge bioinformatics analysis, enabling researchers to delve deeper into the nuances of immune responses. ...
High-throughput sectioning and optical imaging analysis of tissue samples using traditional tissue analysis techniques are expensive and difficult to obtain 3D information. ...
This platform combines artificial intelligence and machine learning to streamline data processing, analysis, and model construction throughout the drug development process. ...
CD Formulation, a leading CRO specialized in pharmaceutical formulation, has launched a new prescription screening process analysis service for both existing and new customers across the globe. ...
The samples to be tested and analyzed could be in the form of solids, semi-solids, liquids, or gases. In brief, pharmaceutical analysis involves a series of processes, including identification, determination, quantitation, and purification. Throughout this process, qualitative analysis and quantitative analysis ...
Eikonoklastes Therapeutics, a preclinical biotech company developing treatments for today’s most challenging diseases, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced a manufacturing partnership that will advance Eikonoklastes’ AAV-based gene therapy, ET-101, into clinical trials for the treatment of patients with ...
Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide. Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug development and drug ...
Based on proven second-generation sequencing and third-generation whole-genome sequencing platforms, CD Genomics provides comprehensive and reliable phage whole-genome de novo sequencing, resequencing, and genetic analysis services. These sequencing technologies are also tools for understanding biochemical interactions between prokaryotes and phages and have been widely used in ...
Enables gene therapy clients to accelerate AAV manufacturing with seamless incorporation into the Company’s HEK 293 platform suspension process with access to end-to-end capabilities New offerings of Research-Grade and GMP-Pathway expedite Phase 1/2 clinical trial timelines, with GMP-Grade available in 2023 Data to support Company’s plasmid production is being presented at ...
In addition, its personalized data mining services are equipped with a series of high-throughput biological data analysis and processing features that could help researchers interpret the hybrid information of thousands of gene spots on the chip. ...
Proteomic data is highly complex and requires powerful but controllable analytical tools for processing and analysis. In drug discovery, most drug targets are families of proteins, but genomes rarely predict changes in form, abundance, or function. ...
Together with state-of-the-art analytical instruments, the company is capable of conducting analytical process development and validation services for drug formulation projects. ...
Used for decades in the biopharmaceutical field, mass spectrometry’s potential has been severely limited because of how slow and complicated the analysis can be. Andson Biotech’s solutions simplify workflows and enable direct-from-production line mass spectrometry analysis. ...
Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory payloads to solid tumors after IV dosing, announced today the significant expansion of its senior leadership team. Dr. Julie Cherrington joins as BOD Chair, James Stutz joins as Chief Business Officer, and Dr. Omkar Joshi joins as Vice President, Technical ...
This month ARTES Biotechnology celebrates its 20th anniversary. The whole team is very thrilled and we think it is time to give a small overview on company’s history. In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals as part of a severance agreement. He was absolute sure that this will be an interim solution only while ...
Bio-Me offers a wide range of proprietary solutions to facilitate the gut microbiome analysis process for academia and pharma researchers and is setting the standard for next-generation routine microbiome analysis with its Precision Microbiome Profiling (PMP™) platform. PMP™ enables rapid, accurate, and highly reproducible microbiome ...
ByBio-Me
Basics and advanced methods of M/EEG data analysis in human brain #research will be covered extensively. Briefly, the workshop will include a journey from basic data review and pre-processing through source analysis and source imaging, arriving at connectivity analysis and group statistics. ...